OPCH

Option Care Health, Inc. NASDAQ

Healthcare ·Medical - Care Facilities ·US · optioncarehealth.com

$20.03

Mkt Cap $3.2B

52w Low $18.02 10.7% of range 52w High $36.80

50d MA $29.61 200d MA $29.99

P/E (TTM) 15.7x

EV/EBITDA 10.1x

P/B 2.4x

Debt/Equity 0.0x

ROE 15.7%

P/FCF 19.5x

RSI (14) —

ATR (14) —

Beta 0.95

50d MA $29.61

200d MA $29.99

Avg Volume 1.8M

About

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the trea…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 30, 2026	BMO	0.37	0.40	+8.1%	26.87	-26.4%	-24.3%	-25.5%	—	—	—	—	—
Feb 24, 2026	BMO	0.46	0.46	+0.0%	36.09	-7.1%	-6.3%	-6.9%	-11.6%	-10.1%	-12.4%	-23.1%	—
Oct 30, 2025	BMO	0.43	0.45	+4.7%	28.67	-9.4%	-8.6%	-9.2%	-7.8%	-5.7%	-5.5%	+7.9%	—
Jul 30, 2025	BMO	0.40	0.41	+2.5%	30.13	-2.6%	+1.7%	-2.6%	-6.2%	-6.2%	-6.7%	-4.8%	—
Apr 29, 2025	BMO	0.36	0.40	+11.1%	32.97	+2.7%	-6.9%	-2.0%	-2.4%	-0.1%	-0.5%	-2.2%	—
Feb 26, 2025	BMO	0.33	0.35	+6.1%	32.63	-3.6%	+1.6%	+1.7%	+2.7%	+4.1%	+4.6%	+6.4%	—
Oct 30, 2024	BMO	0.31	0.31	+0.0%	30.50	-19.6%	-22.8%	-24.5%	-21.0%	-26.3%	-26.8%	-22.0%	—
Jul 31, 2024	BMO	0.27	0.30	+11.1%	31.35	+2.5%	-5.3%	-1.9%	+0.8%	-5.3%	-5.0%	+2.1%	—
Apr 23, 2024	BMO	0.23	0.26	+13.0%	30.41	+1.9%	+0.6%	-1.6%	-3.7%	-2.6%	-0.5%	-6.0%	—
Feb 22, 2024	BMO	0.29	0.32	+10.3%	33.36	+1.9%	-2.4%	-3.4%	-6.3%	-1.8%	-5.2%	-1.9%	—
Oct 25, 2023	BMO	0.28	0.31	+10.7%	32.87	-2.6%	-15.5%	-15.6%	-19.0%	-18.4%	-15.6%	-8.1%	—
Jul 27, 2023	BMO	0.22	0.63	+186.4%	32.44	+4.8%	+4.4%	+5.3%	+4.1%	+4.0%	+3.7%	+7.2%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 1	UBS	Maintains	Buy → Buy	—	$20.33	$20.20	-0.6%	-1.5%	—	—	—	—
May 1	TD Cowen	Maintains	Hold → Hold	—	$20.33	$20.20	-0.6%	-1.5%	—	—	—	—
May 1	Barrington Research	Maintains	Outperform → Outperform	—	$20.33	$20.20	-0.6%	-1.5%	—	—	—	—
Jan 16	Barrington Research	Maintains	Outperform → Outperform	—	$36.11	$35.92	-0.5%	-0.2%	-0.9%	+0.4%	+1.3%	+0.4%
Jan 13	Citizens	Maintains	Market Outperform → Market Outperform	—	$32.06	$35.25	+10.0%	+8.4%	+10.8%	+12.6%	+12.4%	+11.6%
Jan 13	Morgan Stanley	Maintains	Overweight → Overweight	—	$32.06	$35.25	+10.0%	+8.4%	+10.8%	+12.6%	+12.4%	+11.6%
Dec 9	Deutsche Bank	Maintains	Buy → Buy	—	$30.59	$30.81	+0.7%	+5.3%	+8.2%	+7.6%	+8.7%	+9.6%
Dec 9	BofA Securities	Maintains	Buy → Buy	—	$30.59	$30.81	+0.7%	+5.3%	+8.2%	+7.6%	+8.7%	+9.6%
Nov 3	TD Cowen	Maintains	Hold → Hold	—	$26.03	$26.03	+0.0%	+1.5%	+3.8%	+4.0%	+3.9%	+6.2%
Oct 31	Citizens	Maintains	Market Outperform → Market Outperform	—	$26.21	$26.02	-0.7%	-0.7%	+0.8%	+3.1%	+3.3%	+3.2%
Oct 31	Barrington Research	Maintains	Outperform → Outperform	—	$26.21	$26.02	-0.7%	-0.7%	+0.8%	+3.1%	+3.3%	+3.2%
Sep 23	Barrington Research	Maintains	Outperform → Outperform	—	$28.67	$28.74	+0.2%	-3.4%	-4.1%	-6.5%	-4.8%	-3.9%
Jul 31	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$30.64	$30.52	-0.4%	-4.2%	-7.8%	-7.8%	-8.3%	-8.9%
Jul 10	Barrington Research	Maintains	Outperform → Outperform	—	$30.64	$30.56	-0.3%	-0.5%	-2.5%	+0.1%	+0.3%	-0.8%
Jun 18	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$31.84	$31.83	-0.0%	-0.9%	-1.0%	-2.5%	+1.3%	-0.2%
Apr 30	UBS	Upgrade	Neutral → Buy	—	$30.69	$31.28	+1.9%	+5.3%	+4.8%	+7.4%	+6.9%	+6.7%
Apr 30	Barrington Research	Maintains	Outperform → Outperform	—	$30.69	$31.28	+1.9%	+5.3%	+4.8%	+7.4%	+6.9%	+6.7%
Apr 22	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$31.25	$31.43	+0.6%	+0.9%	+2.8%	+3.0%	+5.3%	+5.5%
Apr 21	Barrington Research	Maintains	Outperform → Outperform	—	$32.02	$31.88	-0.4%	-2.4%	-1.5%	+0.3%	+0.5%	+2.7%
Mar 6	JP Morgan	Maintains	Overweight → Overweight	—	$34.60	$34.38	-0.6%	-1.0%	-1.7%	-3.5%	-3.4%	-4.9%
Feb 27	Barrington Research	Maintains	Outperform → Outperform	—	$33.15	$33.33	+0.5%	+0.2%	+1.1%	+2.4%	+2.9%	+4.4%
Jan 24	JP Morgan	Maintains	Overweight → Overweight	—	$30.00	$29.81	-0.6%	+1.1%	+4.7%	+2.8%	+3.2%	+4.7%
Jan 23	Jefferies	Upgrade	Hold → Buy	—	$29.31	$30.43	+3.8%	+2.4%	+3.5%	+7.2%	+5.2%	+5.6%
Jan 14	Barrington Research	Maintains	Outperform → Outperform	—	$27.72	$27.97	+0.9%	+3.6%	+3.8%	+5.8%	+5.2%	+6.3%
Jan 10	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$24.14	$23.68	-1.9%	-0.6%	+14.8%	+19.0%	+19.1%	+21.5%
Nov 5	Goldman Sachs	Downgrade	Buy → Neutral	—	$22.49	$22.42	-0.3%	-0.8%	+4.5%	+2.0%	-0.0%	+1.6%
Nov 1	Truist	Maintains	Buy → Buy	—	$23.04	$23.09	+0.2%	+4.6%	-2.4%	-3.1%	+2.0%	-0.5%
Oct 31	Barrington Research	Maintains	Outperform → Outperform	—	$23.55	$23.41	-0.6%	-2.2%	+2.4%	-4.5%	-5.2%	-0.2%
Oct 31	Jefferies	Downgrade	Buy → Hold	—	$23.55	$23.41	-0.6%	-2.2%	+2.4%	-4.5%	-5.2%	-0.2%
Oct 23	Barrington Research	Maintains	Outperform → Outperform	—	$30.34	$30.27	-0.2%	-1.0%	-1.9%	-2.9%	-0.6%	+0.5%
Sep 30	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$31.42	$31.42	+0.0%	-0.4%	-4.0%	-4.9%	-6.8%	-7.2%
Aug 1	Barrington Research	Maintains	Outperform → Outperform	—	$29.69	$29.97	+0.9%	+3.6%	+6.5%	+0.0%	+0.3%	-1.5%
Jul 25	Barrington Research	Maintains	Outperform → Outperform	—	$30.99	$31.08	+0.3%	+0.0%	+0.5%	-0.4%	+1.2%	-4.2%
Apr 24	Barrington Research	Maintains	Outperform → Outperform	—	$30.59	$30.84	+0.8%	-2.2%	-4.2%	-3.2%	-1.1%	-2.3%
Mar 4	Jefferies	Maintains	Buy → Buy	—	$32.12	$32.19	+0.2%	+2.1%	+1.2%	+0.8%	+2.6%	+0.7%
Feb 23	Barrington Research	Maintains	Outperform → Outperform	—	$32.55	$32.57	+0.1%	-1.0%	-3.9%	+0.6%	-2.9%	-0.9%
Oct 26	Barrington Research	Maintains	Outperform → Outperform	—	$27.78	$28.15	+1.3%	-0.2%	-4.1%	-3.4%	-0.2%	+3.2%
Oct 18	JP Morgan	Maintains	Overweight → Overweight	—	$33.01	$32.97	-0.1%	-2.2%	-2.1%	-2.3%	-2.6%	-0.4%
Jul 28	Barrington Research	Maintains	Outperform → Outperform	—	$33.86	$34.32	+1.4%	+0.9%	-0.2%	-0.4%	-0.6%	-0.7%
Jun 27	Truist	Maintains	Buy → Buy	—	$31.87	$31.63	-0.8%	-1.4%	-1.8%	+0.2%	+1.9%	+1.7%
May 5	Deutsche Bank	Maintains	Buy → Buy	—	$27.50	$27.78	+1.0%	+1.7%	+2.4%	-0.6%	-1.9%	-1.2%
May 5	Barrington Research	Maintains	Outperform → Outperform	—	$27.50	$27.78	+1.0%	+1.7%	+2.4%	-0.6%	-1.9%	-1.2%
Oct 28	Barrington Research	Maintains	Outperform → Outperform	—	$30.78	$30.67	-0.4%	+1.4%	-1.7%	-1.5%	-2.5%	-1.5%
Aug 22	Goldman Sachs	Maintains	Buy → Buy	—	$32.32	$32.44	+0.4%	+0.1%	-0.4%	+1.1%	+1.4%	-2.3%
Jul 28	Barrington Research	Maintains	Outperform → Outperform	—	$33.16	$33.24	+0.2%	+2.3%	+1.3%	+2.1%	+5.5%	+4.8%
Aug 4	Canaccord Genuity	Maintains	Buy → Buy	—	$21.29	$21.00	-1.4%	-4.5%	+0.5%	+3.7%	+2.0%	+0.9%
Jul 19	Goldman Sachs	Upgrade	Neutral → Buy	—	$19.98	$20.28	+1.5%	+0.6%	+4.2%	+6.6%	+6.3%	+6.3%
Mar 12	Canaccord Genuity	Maintains	Buy → Buy	—	$20.72	$20.90	+0.9%	-3.4%	+2.9%	-3.7%	-4.3%	-9.1%
Jan 22	Deutsche Bank	Maintains	Buy → Buy	—	$19.33	$19.50	+0.9%	+1.3%	+1.6%	-0.6%	-6.1%	-2.8%
Jan 11	JP Morgan	Maintains	Overweight → Overweight	—	$16.78	$16.94	+1.0%	+3.9%	+1.4%	+0.0%	-1.1%	+5.2%

Recent Filings

8-K · 7.01 ! Medium

Option Care Health, Inc. -- 8-K 7.01: Regulation FD Disclosure

Option Care Health (OPCH) disclosed supplemental presentation materials to investors via Regulation FD, providing additional context beyond their press release without formal SEC filing implications.

Apr 30

8-K · 1.01 ! Medium

Unknown — 8-K 1.01: Financing / Debt Agreement

Bank of America's debt restructuring likely indicates refinancing activity that could improve liquidity terms, potentially benefiting shareholders if rates are favorable or covenant flexibility increases.

Apr 2

8-K

Option Care Health, Inc. -- 8-K Filing

Option Care Health reported fourth quarter and full year 2025 financial results, with the filing signed by CFO Meenal Sethna on February 24, 2026.

Feb 24

Data updated apr 26, 2026 5:38pm · Source: massive.com